Molecular diagnostic company Myriad Genetics has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test for hereditary cancer testing. The new test analyses 25 genes that are associated with breast, colorectal, ovarian, ...
Tags: Multi-Gene Test, Medicine
The government and NHS will invest £1bn in technology over the next three years in a bid to improve patient care and ease pressure on A&E departments, health secretary Jeremy Hunt announced today. The move is part of ongoing efforts ...
Tags: Computer Products, software
Abbott has unveiled preliminary results from a study that is being carried out by the University of Edinburgh researchers on the company’s Architect Stat High Sensitive Troponin-I (hsTnI) test, at ESC (European Society of Cardiology) ...
Dako, a Danish provider of tissue-based cancer diagnostics, and Omnyx, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, have launched clinical image analysis for digital pathology in Europe. As part of the ...
Tags: Health, Medicine, digital pathology
The US Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist line of ready-to-administer prefilled generic injectables. The third BD Simplist product to be introduced includes Ondansetron ...
Dell(NASDAQ:DELL) has unveiled newest additions to its line of commercial PCs - the Latitude 7000 Series Ultrabooks, Latitude 5000 Series and Latitude 3000 Series laptops. With this new suite, Dell balances sophisticated design, quality ...
Tags: dell, Computer Products, Laptop
US-based Provision Center for Proton Therapy has selected RaySearch Laboratories' RayStation treatment planning system as part of a partnership signed earlier in 2013 by both firms. Provision Center for Proton Therapy president Mary Lou ...
Oasis Medical, a US-based manufacturer and distributor of high quality disposable surgical instruments and ocular lubricating and cleansing solutions, has launched its new 6.25mm Oasis Iris Expander for pupil dilation and sustaining ...
Tags: Oasis Medical, Medicine
Pathogenica has received the CE mark for its HAI BioDetection kit that runs on the Ion PGM benchtop sequencer. HAI BioDetection CE-IVD kit is a qualitative in vitro test designed for the rapid identification of bacterial organisms and ...
Tags: Pathogenica, CE Mark
The US Food and Drug Administration (FDA) has cleared Given Imaging’s next-generation video capsule, called PillCam SB 3. The 11 mm x 26 mm video capsule is helpful in detecting small bowel abnormalities related to Crohn's disease, ...
Tags: PillCam SB 3, Drug
LDR has received a letter of approval from the US Food and Drug Administration (FDA) for commercial sale and distribution of its Mobi-C Cervical Disc (Mobi-C), for one-level indications in the US. The Mobi-C is designed for cervical disc ...
Tags: Mobi-C Cervical Disc
Hologic has received the US Food and Drug Administration (FDA) clearance for its Single Energy (SE) femur exam, designed to visualize features associated with AFFs quickly and conveniently at the time of osteoporosis assessment. The quick ...
Tags: Hologic, FDA Clearance
BioDerm has partnered with Eloquest Healthcare, a wholly owned subsidiary of Ferndale Pharma Group, to introduce its next generation urinary management devices into the acute care market. BioDerm is the manufacturer of the ReliaFit male ...
Japan-based Takeda Pharma has received positive CHMP opinion for its three new type 2 diabetes therapies from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The therapies include Vipidia ...
Tags: Therapies, CHMP Opinion
US-based Eloquest Healthcare has launched ReliaFit Male Urinary Device, a next-generation external catheter that reduces the risk of urinary tract infections usually related with indwelling catheters. ReliaFit also offers a high level of ...
Tags: Male Urinary Device, Health